See where GSK's $6.6B R&D spend ranks; hint: It's not in the top 5

GlaxoSmithKline reduced its research and development spending last year by 1 percent, but still spent more than all but six drug companies in that area...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.